Open Access

miR‑130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways

  • Authors:
    • Li Jia
    • Bin Lei
    • Huaijun Gao
    • Lin Jia
    • Dan Luo
    • Jianjun Han
    • Bingxin Jia
  • View Affiliations

  • Published online on: December 1, 2021     https://doi.org/10.3892/etm.2021.11021
  • Article Number: 98
  • Copyright: © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostate cancer occurs in the prostatic epithelium and poses a threat to the health of middle‑aged and older males. The objective of the present study was to explore the roles of microRNA (miRNA/miR)‑130b in prostate cancer and potential molecular mechanisms in order to control the migration and invasion of prostate cancer. For this purpose, reverse transcription‑PCR was performed to evaluate the mRNA levels of DLL1, phosphoinositide‑3 kinase (PI3K), protein kinase B (Akt) and matrix metalloproteinase (MMP)9, and western blot analysis was carried out to detect the protein expression levels of DLL1, phosphorylated (p)‑PI3K, p‑Akt and MMP9. A Transwell assay was conducted to examine the invasion rate of prostate cancer cells. Furthermore, a scratch wound assay was performed to examine the migration rate of prostate cancer cells. A luciferase assay was performed to examine the interaction between miRNA and its target mRNA. The results revealed that miR‑130b had abnormal (low) expression in tumor tissues compared with that in the adjacent normal tissue. An miR‑130b mimic suppressed the expression of DLL1. The expression of p‑PI3K, p‑Akt and MMP9 in prostate cancer cells transfected with the miR‑130b mimic was decreased in comparison to the negative control and control groups. Furthermore, migration and invasion were significantly suppressed in the miR‑130b mimic group. In conclusion, a novel pathway interlinking miR‑130b and MMP9, p‑Akt and p‑PI3K, which regulates the migration and invasion of prostate cancer cells, was identified. These findings provide an intriguing biomarker and treatment strategy for patients with prostate cancer.
View Figures
View References

Related Articles

Journal Cover

January-2022
Volume 23 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jia L, Lei B, Gao H, Jia L, Luo D, Han J and Jia B: miR‑130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways. Exp Ther Med 23: 98, 2022
APA
Jia, L., Lei, B., Gao, H., Jia, L., Luo, D., Han, J., & Jia, B. (2022). miR‑130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways. Experimental and Therapeutic Medicine, 23, 98. https://doi.org/10.3892/etm.2021.11021
MLA
Jia, L., Lei, B., Gao, H., Jia, L., Luo, D., Han, J., Jia, B."miR‑130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways". Experimental and Therapeutic Medicine 23.1 (2022): 98.
Chicago
Jia, L., Lei, B., Gao, H., Jia, L., Luo, D., Han, J., Jia, B."miR‑130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways". Experimental and Therapeutic Medicine 23, no. 1 (2022): 98. https://doi.org/10.3892/etm.2021.11021